Increases in protein A24 following treatment of Ehrlich ascites tumor cells with 1-methyl-1-nitrosourea and 1,3-bis(2-chloroethyl)-1-nitrosourea.
D000818:Animals; D002286:Carcinoma, Ehrlich Tumor / Q000378:metabolism*; D002330:Carmustine / Q000494:pharmacology*; D002478:Cells, Cultured; D002868:Chromosomal Proteins, Non-Histone / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D004591:Electrophoresis, Polyacrylamide Gel; D006657:Histones / Q000378:metabolism*; D008190:Lyases / Q000037:antagonists & inhibitors; D008770:Methylnitrosourea / Q000494:pharmacology*; D009607:Nitrosourea Compounds / Q000494:pharmacology*; D014452:Ubiquitins
D002868:Chromosomal Proteins, Non-Histone; D006657:Histones; D009607:Nitrosourea Compounds; D014452:Ubiquitins; C021645:chromatin conjugate protein A24; D008770:Methylnitrosourea; D008190:Lyases; D002330:Carmustine